immunodeficiency

RAMSEY, N.J. and BOCA RATON, Fla., May 04, 2026 ADMA Biologics has secured U.S. FDA approval to expand the...

LEIDEN, Netherlands, March 27, 2026 Pharming Group N.V. announced that the Committee for Medicinal Products for Human Use (CHMP)...

LEIDEN, NETHERLANDS, March 24, 2026 Pharming Group has announced that Japan’s Ministry of Health, Labour and Welfare has approved...